Statements of each of our partnership institutions in light of the murder of George Floyd
About
About Us
Our Team
Publications
Research
Project 1 – Prostate
Project 2 – Pancreas
Pilot Project 1 – Pancreas
Pilot Project 2 – Prostate
Pilot Project 3 – Lung
Pilot Project 4 – Pancreas
Education
Summer-CaRE2 Training Program
Postbac-CaRE2 Training Program
Grad+ CaRE2
Outreach & Engagement
Cancer Citizen Scientist Program
Cancer Education Programs
Cancer Information and Education Materials
COVID-19 Resources
Resources
Developmental Research Projects Awards
Tissue Modeling Core
Bioinformatics Core
COVID-19 Resources
Planning & Evaluation
News & Events
Contact
Menu
About
About Us
Our Team
Publications
Research
Project 1 – Prostate
Project 2 – Pancreas
Pilot Project 1 – Pancreas
Pilot Project 2 – Prostate
Pilot Project 3 – Lung
Pilot Project 4 – Pancreas
Education
Summer-CaRE2 Training Program
Postbac-CaRE2 Training Program
Grad+ CaRE2
Outreach & Engagement
Cancer Citizen Scientist Program
Cancer Education Programs
Cancer Information and Education Materials
COVID-19 Resources
Resources
Developmental Research Projects Awards
Tissue Modeling Core
Bioinformatics Core
COVID-19 Resources
Planning & Evaluation
News & Events
Contact
FDA Approval
By
Jose Aparicio
December 2, 2021
We are excited to announce that Tissue Modeling Core Co-Leader Dr Paul Okunieff and the company he founded DiaCarta have received FDA approval for their Covid-19 Test that is able to detect covid-19 variants using an algorithm they developed.
https://www.prnewswire.com/news-releases/diacartas-multivariant-covid-19-test-accurately-detects-the-omicron-variant-301434105.html?tc=eml_cleartime
Share on facebook
Facebook
Share on google
Google+
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on pinterest
Pinterest